FLORetina ICOOR 2025

Imagine Eyes will exhibit at the FLORetina-ICOOR meeting in Florence on December 04-07, 2025.

We warmly welcome all attendees to visit us on booth #4 and discover a new range of possibilities for investigating retinal disease at the cellular and microvascular level, and for advancing the development of retinal therapies.

Cellular and microvascular retinal assessments for clinical research and clinical trials

The rtx1 adaptive optics retinal camera reveals subclinical and clinical alterations at the microscopic scale through quick exams, and provides quantification of cone cells, RPE cells and microvascular structure. Extensively validated by 250+ published studies, rtx1 enables investigating various retinal diseases, and sensitive monitoring of disease progression as well as therapy effects – over shorter timescales than OCT or AF imaging.

The rtx1 AO camera comes to Floretina with exciting new features, that streamline its implementation in clinical studies and trials, and extends investigations to new candidate biomarkers. We will be happy to introduce all its current capabilities with live demos.

 

 

For trial sponsors and CROs

We offer global services for a successful implementation of AO biomarkers in studies and trials, through the global clinical trial equipement network of our partner Emsere. Meet us at EURETINA to discuss how to accelerate your developments of retinal therapies.